动态3D微流体平台,用于探索结合向治疗,化疗和病毒疗法在卵巢癌的治疗
Lukasz Kuryk1,2, Sara Mathlouthi1, Lisa Casagrande1
1Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via F. Marzolo 5, 35131, Padua, Italy.
Drug delivery and translational research
|November 3, 2025
概括
一种新的卵巢癌治疗策略,使用型病毒 (OV) 和化疗,对最佳效果进行测序,在3D瘤模型中显示出有前途的结果. 这种方法可以增强免疫反应并减少瘤的再生,为卵巢癌治疗提供了一条新的途径.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物技术是生物技术.
背景情况:
- 卵巢癌由于晚期诊断,复发和治疗耐药性而带来了重大治疗挑战.
- 瘤病毒 (OV) 是有前途的,但受到免疫抑制性瘤微环境 (TME) 和不良传递的限制.
- 现有的模型难以准确地复制体内药理动力学和瘤药物相互作用.
研究的目的:
- 通过使用动态微流体基的3D活体瘤模型,评估卵巢癌的系统性,多模式治疗策略.
- 研究治疗序列对血管化瘤微环境中的治疗疗效的影响.
主要方法:
- 开发一个3D活体瘤模型,使用可 perfusable 球体,外围血液单核细胞 (PBMC) 和内皮细胞 (HUVEC).
- 通过基于流动的循环进行瘤性腺病毒 (Ad5/3-D24-ICOSL-CD40L),西斯普拉丁,帕克利塔克塞尔和宁泰达尼布的全身注射.
- 化疗前的原始化疗方案 (化疗前48小时的原始化疗) 与同时使用的治疗方案的比较.
主要成果:
- 原始化疗法显著优于联合使用,减少球状体大小并防止瘤反弹.
- 增强的治疗反应与增加的病毒复制,免疫细胞死亡和免疫细胞透相关.
- 瘤在芯片平台使实时监测治疗反应和免疫激活在连续流下.
结论:
- 对型病毒和化疗的测序对于优化卵巢癌治疗至关重要.
- 微环境预条件增强了多模式癌症治疗的有效性.
- 这种3D外体模型作为一个强大的临床前工具,用于推进个性化卵巢癌疗法.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


